Prof. R.F. van Vollenhoven PhD

Prof. PhD R.F. van Vollenhoven

Position

Full Professor

Main activities

Education, Patient care, Research, Other

Specialisation

Rheumatology

Focus of research

Optimal use of innovative therapies for autoimmune inflammatory diseases.

Disease areas most studied are rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).

Methodologies include investigator-initiated clinical trials, (international) registries, and studies based on direct patient contact.

Novel therapeutic strategies (e.g., treat-to-target, induction-maintenance), novel methods of doing clinical trials ('the learning healt care environment'), use of imaging in clinical care, are among the most noted recent topics of the research in my group.

Amsterdam UMC Research Institutes

AII - Inflammatory diseases

AMC departments

Clinical Immunology and Rheumatology

Key publications

Lee Eun Bong, Fleischmann Roy, Hall Stephen, Wilkinson Bethanie, Bradley John D., Gruben David, Koncz Tamas, Krishnaswami Sriram, Wallenstein Gene V., Zang Chuanbo, Zwillich Samuel H., van Vollenhoven Ronald F., Lue Cummins, Schnitz William Martin, Baraf Herbert Stuart Block, Bolster Marcy Behar, Kivitz Alan Jan, Kimmel Steven Charles, Fudman Edward Joel, Quaidoo Emmanuel Adolphus, Churchill Melvin Albert, Birbara Charles Allen, Longley Selden, Stohl William, Niemer Mark William, Payne Dayton Dennis, Kaine Jeffrey Louis, Kafka Shelly Pearl, Fleischmann Roy Mitchell, Charles-Schoeman Christina Marie, Kavanaugh Arthur Francis, Kremer Joel Marc, Ritter Jeffrey Sanders, Stack Michael Thomas, Barron Melanie Creech, Aelion Jacob Asher, Griffin Robert Michael, Peng Stanford Lee-Yu, Walsh Bridget Tyrell, Silverfield Joel Charles, Ghirlanda Mariano Ricardo, Tate Guillermo A., Citera Gustavo, Ximenes Antonio Carlos, Radominski Sebastiao Cezar, Keiserman Mauro W., Zerbini Cristiano Augusto de Freitas, Calabresse Renato Jimenez, Cabezas Pedro Claudio Miranda, Ponce Lucia Tofacitinib versus Methotrexate in Rheumatoid Arthritis New England journal of medicine 2014;370 (25):2377-2386 [PubMed]
van Vollenhoven Ronald F., Geborek Pierre, Forslind Kristina, Albertsson Kristina, Ernestam Sofia, Petersson Ingemar F., Chatzidionysiou Katerina, Bratt Johan, Cöster Lars, Zickert Agneta, Theander Jan, Thörner Åke, Hellström Helena, Teleman Annika, Dackhammar Christina, Akre Finn, Ljung Lotta, Oding Rolf, Wörnert Margareta Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial Lancet 2012;379 (9827):1712-1720 [PubMed]
van Vollenhoven Ronald F., Fleischmann Roy, Cohen Stanley, Lee Eun Bong, Garcia Meijide Juan A., Wagner Sylke, Forejtova Sarka, Zwillich Samuel H., Gruben David, Koncz Tamas, Wallenstein Gene V., Krishnaswami Sriram, Bradley John D., Wilkinson Bethanie, Bossingham David H., Hall Stephen, Nash Peter T., Schrieber Leslie, Sokolovic Sekib, Oparanov Boycho, Yablanski Kiril, Batalov Anastas, Bichovska Daniela, Goranov Ivan, Nikolov Nikolay G., Chow Andrew, Klinkhoff Alice V., Beaulieu Andre Damien, Pope Janet, Tremblay Jean-Luc, Nair Bindu, Wilson Diane B., Aliste Marta, Ballesteros Francisco, Holuigue Gloria, Flores Ana Maria, Alpizar Raul, Brenes-Silesky Francisco, Alfaro-Vargas Daniel, Kaliterna Dusanka Martinovic, Cikes Nada, Prus Visnja, Rosa Jan, Nemec Petr, Vitek Petr, Dvorak Zdenek, Novosad Libor, Urbanova Zuzana, Mosterova Zdenka, Danneskiold-Samsoe Bente Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis New England journal of medicine 2012;367 (6):508-519 [PubMed]
Hambardzumyan Karen, Bolce Rebecca, Saevarsdottir Saedis, Cruickshank Scott E., Sasso Eric H., Chernoff David, Forslind Kristina, Petersson Ingemar F., Geborek Pierre, van Vollenhoven Ronald F. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial Annals of the rheumatic diseases 2015;74 (6):1102-1109 [PubMed]
van Vollenhoven Ronald F., Mosca Marta, Bertsias George, Isenberg David, Kuhn Annegret, Lerstrøm Kirsten, Aringer Martin, Bootsma Hendrika, Boumpas Dimitrios, Bruce Ian N., Cervera Ricard, Clarke Ann, Costedoat-Chalumeau Nathalie, Czirják László, Derksen Ronald, Dörner Thomas, Gordon Caroline, Graninger Winfried, Houssiau Frédéric, Inanc Murat, Jacobsen Søren, Jayne David, Jedryka-Goral Anna, Levitsky Adrian, Levy Roger, Mariette Xavier, Morand Eric, Navarra Sandra, Neumann Irmgard, Rahman Anisur, Rovensky Jozef, Smolen Josef, Vasconcelos Carlos, Voskuyl Alexandre, Voss Anne, Zakharova Helena, Zoma Asad, Schneider Matthias Treat-to-target in systemic lupus erythematosus: recommendations from an international task force Annals of the rheumatic diseases 2014;73 (6):958-967 [PubMed]